Literature DB >> 26935943

Survivorship After Periprosthetic Femur Fracture: Factors Affecting Outcome.

Jacob M Drew1, William L Griffin2, Susan M Odum3, Bryce Van Doren3, Brock T Weston3, Louis S Stryker4.   

Abstract

BACKGROUND: Data addressing risk factors predictive of mortality and reoperation after periprosthetic femur fractures (PPFxs) are lacking. This study examined survivorship and risk ratios for mortality and reoperation after surgical treatment for PPFx and associated clinical risk factors.
METHODS: A retrospective review was performed for 291 patients treated surgically for PPFx between 2004 and 2013. Primary outcomes were death and reoperation.
RESULTS: Mortality at 1 year was 13%, whereas the rate of reoperation was 12%. Greater span of fixation and revision arthroplasty (vs open reduction internal fixation) trended toward a lower likelihood of reoperation.
CONCLUSION: After PPFx, patients have a 24% risk of either death or reoperation at 1 year. Factors contributing to increased mortality are nonmodifiable. Risk of reoperation is minimized with greater span of fixation and performance of revision arthroplasty.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  mortality; periprosthetic fracture; revision total hip arthroplasty; revision total knee arthroplasty; total hip arthroplasty; total knee arthroplasty

Mesh:

Year:  2015        PMID: 26935943     DOI: 10.1016/j.arth.2015.11.038

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  22 in total

1.  Biomechanics of periprosthetic femur fractures and early weightbearing.

Authors:  Ansab Khwaja; William Mahoney; Jay Johnson; Alex Trompeter; Jason Lowe
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-04-14

2.  Reliability of the commonly used classification systems for interprosthetic fractures.

Authors:  Toby Jennison; Abdulla Jawed; Ahmed ElBakoury; Hazem Hosny; Rathan Yarlagadda
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-03-18

Review 3.  Periprosthetic fractures: epidemiology and current treatment.

Authors:  Antonio Capone; Stefano Congia; Roberto Civinini; Giuseppe Marongiu
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

4.  The value of a standardized and reproducible surgical technique in treatment of Vancouver B2 periprosthetic fractures: our experience.

Authors:  Stefano Biggi; Andrea Camera; Riccardo Tedino; Andrea Capuzzo; Stefano Tornago
Journal:  Eur J Trauma Emerg Surg       Date:  2018-06-19       Impact factor: 3.693

5.  High reoperation and mortality rate after distal femoral replacement for periprosthetic knee fracture in the elderly.

Authors:  Oriol Pujol; Nayana Joshi-Jubert; Jorge H Nuñez; Joan Pijoan; Enric Castellet; Joan Minguell
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-02-19

6.  The Impact of Femoral Component Cementation on Fracture and Mortality Risk in Elective Total Hip Arthroplasty: Analysis from a National Medicare Sample.

Authors:  Adam I Edelstein; Eric L Hume; Liliana E Pezzin; Emily L McGinley; Timothy R Dillingham
Journal:  J Bone Joint Surg Am       Date:  2022-03-16       Impact factor: 5.284

7.  A case-control study of 30-day mortality in periprosthetic hip fractures and hip fractures.

Authors:  T Jennnison; R Yarlagadda
Journal:  Ann R Coll Surg Engl       Date:  2019-12-02       Impact factor: 1.891

8.  Mortality in patients sustaining a periprosthetic fracture following a hemiarthroplasty.

Authors:  Toby Jennison; Rathan Yarlagadda
Journal:  J Orthop       Date:  2018-05-07

9.  Clinical outcome and quality of life of patients with periprosthetic distal femur fractures and retained total knee arthroplasty treated with polyaxial locking plates: a single-center experience.

Authors:  Sebastian Lotzien; Clemens Hoberg; Martin F Hoffmann; Thomas A Schildhauer
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-06-22

Review 10.  [Periprosthetic fractures of the acetabulum and femur : Causes-classification-treatment algorithms].

Authors:  D M Ates; P Koenen; R Otchwemah; H Bäthis
Journal:  Orthopade       Date:  2019-04       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.